Maidstone, UK, 20th October 2015 - Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography ('OCT') technology, today announces data showing ...

MAIDSTONE, England--(BUSINESS WIRE)--Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces data showing ...

ORPINGTON, UNITED KINGDOM--(Marketwired - Apr 29, 2015) - Michelson Diagnostics, the UK-based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, today ...

Maidstone, UK, 30 April 2015 - Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, today announces the launch of VivoSight ...

Multi-centre, Prospective Study Data Published in Journal of Clinical and Aesthetic Dermatology Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence ...

(Orpington, UK) September 30, 2010 -- Michelson Diagnostics (MDL) the leading provider of clinical OCT imaging systems is pleased to report the use of its VivoSight OCT imaging system to evaluate the ...

MAIDSTONE, England, Aug. 1, 2022 /PRNewswire/ -- A major study published in leading cancer journal, The Lancet Oncology 1 have ground-breaking findings on Michelson Diagnostics, the UK based medical ...

An OCT platform capable of imaging blood vessels and the flow within them could help clinicians treating patients with melanomas to more rapidly diagnose the spread of the cancer, and reduce the need ...

Fig. Effect of VivoSight OCT observation on blood vessel density of subjects.The marked test areas for subjects A-D were the left facial skin, left nasal skin, the back of the left hand, and the left ...

Michelson Diagnostics, the UK-based developer of an OCT scanner targeted at treatment of non-melanoma skin cancer, has announced a further round of investment. The company has raised £607,000 from ...

Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas 2. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the ...